Zeo ScientifiX (ZEOX) 10-K2017 FY Annual report

Filed: 1 Nov 18, 4:13pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. senior Avg

New words: abated, abatement, advisor, aerosol, allogeneic, anapproximately, ancillary, automate, awaiting, backup, bifurcated, Boca, book, briefly, Broward, BS, burden, category, chart, Chicago, Circuit, clarity, complement, Contemporaneously, Coral, CRM, deadline, departure, diagnostic, diversified, durable, ERP, escrow, escrowed, excessive, expedited, explain, exploratory, extinguish, Fifteenth, forensic, forgiven, Fox, fractional, gathering, gene, genetically, Grievance, heavily, hedging, hereinafter, hereunder, host, Hygea, Ifour, inconsistent, inexperienced, infusion, inhalation, input, intradermal, intraocular, IRS, JD, Judicial, levy, locationin, looming, Los, Manuel, Marcum, misleading, misuse, modern, modification, neutral, Notemay, Notification, offset, outlined, Palm, passage, path, PHS, prioritized, proceed, promising, ratio, Raton, reconstituted, redundant, regime, replace, replaced, replacement, resolved, resubmit, resumed, revalued, RMAT, Robert, rounded, route, satisfactorily, Senate, settled, simulation, sooner, spur, streamline, technique, tenor, thereon, thousand, threshold, title, transformative, unduly, unissued, unsafe, upcoming, Utah, Vendaje, Vera, VWAP, yield, Zucker

Removed: adding, British, constructed, currency, deficiency, European, experienced, federally, integrated, translated, twelve, user

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ZEOX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned Manuel Iglesias, Chief Executive Officer and Ian T. Bothwell, Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	the Annual Report on Form 10-K of Organicell Regenerative Medicine, Inc., a Nevada corporation (the “Registrant”), for the fiscal year ended October 31, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: November 1, 2018	/s/ MANUEL IGLESIAS
	Manuel Iglesias
	Chief Executive Officer
	(Principal Executive Officer)

Date: November 1, 2018	/s/ IAN T. BOTHWELL
	Ian T. Bothwell
	Chief Financial Officer
	(Principal Financial and Accounting Officer)